SARS-CoV-2 vaccination in patients with GI and hepatobiliary carcinoma: a call for booster vaccination

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gut 2023-06, Vol.72 (6), p.1227-1229
Hauptverfasser:	Monin, Malte Benedikt, Baier, Leona, Berger, Moritz, Gorny, Jens Gabriel, Zhou, Taotao, Mahn, Robert, Sadeghlar, Farsaneh, Möhring, Christian, van Bremen, Kathrin, Boesecke, Christoph, Rockstroh, Jürgen, Strassburg, Christian, Eis-Hübinger, Anna-Maria, Gonzalez-Carmona, Maria Agnes
Format:	Artikel
Sprache:	eng
Schlagworte:	5-Fluorouracil Antibodies Antibodies, Viral Cancer therapies Chemotherapy CHOLANGIOCARCINOMA Colorectal cancer Colorectal carcinoma Comorbidity COVID-19 COVID-19 - prevention & control COVID-19 Vaccines Editing Enzyme-linked immunosorbent assay Epidermal growth factor Esophageal cancer Ethics Funding Gallbladder Gallbladder cancer Gastric cancer Gemcitabine Growth factors HEPATOBILIARY CANCER HEPATOCELLULAR CARCINOMA Humans Immune checkpoint IMMUNE RESPONSE Infections Irinotecan Liver cancer Liver diseases mRNA Pancreatic cancer Patients Photodynamic therapy PostScript Regression analysis Response rates SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Tumors Vaccination Vaccines Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!